文献速递中枢神经肿瘤放疗放疗物理与技术

肿瘤治疗电场(TTFields)延迟胶质瘤细胞放疗后DNA损伤修复

Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells.
PubMed 文献 · Radiat Oncol · 2017-12-29

本研究在U-118 MG和LN-18胶质瘤细胞中评估TTFields联合放疗的疗效,并利用体模和大鼠模型检测换能器阵列对放疗剂量分布及皮肤毒性的影响。结果显示TTFields可协同增强放疗疗效,可能通过抑制DNA损伤修复(尤其同源重组修复)实现;体模中阵列导致表面剂量显著增加、深层剂量轻度降低,但大鼠皮肤未见额外反应。临床前结果支持放疗后立即应用TTFields。

要点

  • TTFields联合放疗在胶质瘤细胞中显示协同增效作用。
  • TTFields可能通过阻断同源重组修复抑制放疗或博来霉素诱导的DNA损伤修复。
  • 体模中换能器阵列使表面放疗剂量显著增加、20mm与60mm处轻度降低,但大鼠皮肤未出现额外反应。

核心结论

  • 放疗后给予TTFields可增强胶质瘤细胞治疗效果,可能通过抑制DNA损伤修复实现。
  • 临床前结果支持放疗后立即应用TTFields作为增强放疗结局的可行方案。
  • 体模测量与动物模型提示放疗期间可保留换能器阵列而不增加皮肤毒性。

研究设计与样本

  • 体外研究使用U-118 MG和LN-18胶质瘤细胞,评估放疗或博来霉素诱导DNA损伤后应用TTFields的疗效。
  • 采用碱性彗星实验测量DNA损伤修复,通过γH2AX或Rad51焦点分析DNA双链断裂修复,免疫印迹评估pATM(pS1981)和pDNA-PKcs(pS2056)活化。
  • 体模模型测量换能器阵列对放疗能量吸收的影响;大鼠每日经阵列接受2Gy照射(总剂量20Gy)评估皮肤毒性。

主要发现

  • TTFields协同增强放疗在胶质瘤细胞中的疗效。
  • TTFields应用损害放疗或化学诱导的DNA损伤修复,可能通过阻断同源重组修复。
  • 换能器阵列导致其下方20mm和60mm处放疗强度轻度降低,但体模表面放疗剂量显著增加,危及「皮肤保护效应」。
  • 放疗期间大鼠皮肤放置换能器阵列未导致额外皮肤反应。

临床怎么用

  • 临床前证据支持在放疗后立即应用TTFields以增强放疗疗效。
  • 体模与动物模型提示放疗期间可保留换能器阵列而不增加皮肤毒性,但需注意表面剂量增加对皮肤保护效应的潜在影响。

局限性

  • 结论基于临床前细胞、体模和大鼠模型,尚未在患者中验证。
  • 体模中阵列导致表面剂量显著增加,可能危及皮肤保护效应,需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumor Treating Fields (TTFields) are an anti-neoplastic treatment modality delivered via application of alternating electric fields using insulated transducer arrays placed directly on the skin in the region surrounding the tumor. A Phase 3 clinical trial has demonstrated the effectiveness of continuous TTFields application in patients with glioblastoma during maintenance treatment with Temozolomide. The goal of this study was to evaluate the efficacy of combining TTFields with radiation treatment (RT) in glioma cells. We also examined the effect of TTFields transducer arrays on RT distribution in a phantom model and the impact on rat skin toxicity. METHODS: The efficacy of TTFields application after induction of DNA damage by RT or bleomycin was tested in U-118 MG and LN-18 glioma cells. The alkaline comet assay was used to measure repair of DNA lesions. Repair of DNA double strand breaks (DSBs) were assessed by analyzing γH2AX or Rad51 foci. DNA damage and repair signaled by the activation pattern of phospho-ATM (pS1981) and phospho-DNA-PKcs (pS2056) was evaluated by immunoblotting. The absorption of the RT energy by transducer arrays was measured by applying RT through arrays placed on a solid-state phantom. Skin toxicities were tested in rats irradiated daily through the arrays with 2Gy (total dose of 20Gy). RESULTS: TTFields synergistically enhanced the efficacy of RT in glioma cells. Application of TTFields to irradiated cells impaired repair of irradiation- or chemically-induced DNA damage, possibly by blocking homologous recombination repair. Transducer arrays presence caused a minor reduction in RT intensity at 20 mm and 60 mm below the arrays, but led to a significant increase in RT dosage at the phantom surface jeopardizing the "skin sparing effect". Nevertheless, transducer arrays placed on the rat skin during RT did not lead to additional skin reactions. CONCLUSIONS: Administration of TTFields after RT increases glioma cells treatment efficacy possibly by inhibition of DNA damage repair. These preclinical results support the application of TTFields therapy immediately after RT as a viable regimen to enhance RT outcome. Phantom measurements and animal models imply that it may be possible to leave the transducer arrays in place during RT without increasing skin toxicities.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Giladi M, Munster M, Schneiderman RS, et al. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells. Radiat Oncol. 2017. PMID: 29284495. doi:10.1186/s13014-017-0941-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。